Updated Jul 16, 2026
Valle William has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $125K.
William Valle is a corporate executive and director at TriSalus Life Sciences, Inc. He has been involved in the life sciences sector, contributing to the strategic direction of the company. Specific details about his career prior to his role at TriSalus are not widely documented.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-15 | TLSI | TriSalus Life Sciences, Inc. | A — Grant or award | 24.6K | $0.00 | |
| 2026-05-15 | TLSI | TriSalus Life Sciences, Inc. | A — Grant or award | 28.2K | $0.00 | |
| 2026-02-23 | TLSI | TriSalus Life Sciences, Inc. | P — Open-market purchase | 30.5K | $4.10 | $125K |
William Valle is a corporate executive and director at TriSalus Life Sciences, Inc. He has been involved in the life sciences sector, contributing to the strategic direction of the company. Specific details about his career prior to his role at TriSalus are not widely documented.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($125K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Valle William profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.